DE69802921T2 - Arzneizubereitungen in trockner form zur oralen verabreichung einer cyclischen quaternären ammoniumverbindung - Google Patents

Arzneizubereitungen in trockner form zur oralen verabreichung einer cyclischen quaternären ammoniumverbindung

Info

Publication number
DE69802921T2
DE69802921T2 DE69802921T DE69802921T DE69802921T2 DE 69802921 T2 DE69802921 T2 DE 69802921T2 DE 69802921 T DE69802921 T DE 69802921T DE 69802921 T DE69802921 T DE 69802921T DE 69802921 T2 DE69802921 T2 DE 69802921T2
Authority
DE
Germany
Prior art keywords
quaternary ammonium
oral administration
ammonium compound
dry preparations
cyclic quaternary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69802921T
Other languages
English (en)
Other versions
DE69802921D1 (de
Inventor
Bernard Abramovici
Xavier Boulenc
Jean-Claude Gautier
Pol Vilain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of DE69802921D1 publication Critical patent/DE69802921D1/de
Application granted granted Critical
Publication of DE69802921T2 publication Critical patent/DE69802921T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69802921T 1997-02-17 1998-02-17 Arzneizubereitungen in trockner form zur oralen verabreichung einer cyclischen quaternären ammoniumverbindung Expired - Fee Related DE69802921T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701826A FR2759585B1 (fr) 1997-02-17 1997-02-17 Formulations pharmaceutiques presentees sous forme seche pour l'administration orale d'un compose ammonium quaternaire cyclique
PCT/FR1998/000299 WO1998035663A1 (fr) 1997-02-17 1998-02-17 Formulations pharmaceutiques presentees sous forme seche pour l'administration orale d'un compose ammonium quaternaire cyclique

Publications (2)

Publication Number Publication Date
DE69802921D1 DE69802921D1 (de) 2002-01-24
DE69802921T2 true DE69802921T2 (de) 2002-08-29

Family

ID=9503805

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69802921T Expired - Fee Related DE69802921T2 (de) 1997-02-17 1998-02-17 Arzneizubereitungen in trockner form zur oralen verabreichung einer cyclischen quaternären ammoniumverbindung

Country Status (19)

Country Link
US (1) US6303626B1 (de)
EP (1) EP0981340B1 (de)
JP (1) JP2001511796A (de)
AR (1) AR011806A1 (de)
AT (1) ATE210436T1 (de)
AU (1) AU6405098A (de)
BR (1) BR9807406A (de)
CA (1) CA2281607A1 (de)
CO (1) CO4920216A1 (de)
DE (1) DE69802921T2 (de)
DK (1) DK0981340T3 (de)
ES (1) ES2172116T3 (de)
FR (1) FR2759585B1 (de)
HK (1) HK1023509A1 (de)
HR (1) HRP980074A2 (de)
NO (1) NO993927D0 (de)
PT (1) PT981340E (de)
WO (1) WO1998035663A1 (de)
ZA (1) ZA981288B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
CA2536040A1 (en) * 2003-11-04 2005-05-26 Shire Laboratories Inc. Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
DE10355461A1 (de) * 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
CN102188424B (zh) * 2011-03-23 2013-03-27 浙江理工大学 Sr140333的抗血癌作用
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US20140271633A1 (en) * 2013-03-14 2014-09-18 Abbvie Inc. Mammalian cell culture performance through surfactant supplementation of feed media
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676055B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) * 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
FR2696178B1 (fr) * 1992-09-30 1994-12-30 Sanofi Elf Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
US5679693A (en) 1992-09-30 1997-10-21 Sanofi 1-azoniabicyclo 2.2.1!heptanes, method of preparing them and pharmaceutical compositions in which they are present
FR2717802B1 (fr) * 1994-03-25 1996-06-21 Sanofi Sa Nouveaux composés aromatiques, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2717804B1 (fr) 1994-03-25 1996-06-21 Sanofi Sa Sels de composés hétéroaromatiques azotés substitués, procédé pour leur préparation et compositions pharmaceutiques en contenant.
CN1067385C (zh) * 1994-08-25 2001-06-20 默里尔药物公司 用于治疗变应性疾病的新的取代的哌啶类化合物
FR2725986B1 (fr) * 1994-10-21 1996-11-29 Adir Nouveaux derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2725900B1 (fr) * 1994-10-21 1997-07-18 Sanofi Sa Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice
FR2729951B1 (fr) 1995-01-30 1997-04-18 Sanofi Sa Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
ZA981288B (en) 1998-08-26
EP0981340B1 (de) 2001-12-12
PT981340E (pt) 2002-05-31
WO1998035663A1 (fr) 1998-08-20
US6303626B1 (en) 2001-10-16
NO993927L (no) 1999-08-16
NO993927D0 (no) 1999-08-16
FR2759585B1 (fr) 1999-06-11
AU6405098A (en) 1998-09-08
BR9807406A (pt) 2000-03-14
ES2172116T3 (es) 2002-09-16
EP0981340A1 (de) 2000-03-01
JP2001511796A (ja) 2001-08-14
CA2281607A1 (en) 1998-08-20
AR011806A1 (es) 2000-09-13
ATE210436T1 (de) 2001-12-15
FR2759585A1 (fr) 1998-08-21
CO4920216A1 (es) 2000-05-29
DE69802921D1 (de) 2002-01-24
HK1023509A1 (en) 2000-09-15
DK0981340T3 (da) 2002-03-25
HRP980074A2 (en) 1998-10-31

Similar Documents

Publication Publication Date Title
NO179503C (no) Oralt preparat
FI973749A0 (fi) Suun kautta annosteltava 2-metyylitienobentsodiatsepiinivalmiste
NO20001612L (no) Oralt preparat
ATE178489T1 (de) Fluessige oral anzuwendende arzneizubereitungen enthaltend paroxetinresinate
DE69518331T2 (de) Orale zubereitungen
NO171948C (no) Oralt preparat
IS5245A (is) Lyfjablanda úr ómeprasól
NO984881D0 (no) Oralt farmas°ytisk preparat inneholdende ibandronat
DK314089A (da) Orale praeparater
NO308394B1 (no) Oralt preparat
NO179161C (no) Oralt preparat
FI944052A0 (fi) Oraalinen rokote
DE69802921D1 (de) Arzneizubereitungen in trockner form zur oralen verabreichung einer cyclischen quaternären ammoniumverbindung
DE69713171D1 (de) Mundpflegezubereitung
EE200200105A (et) Radiofarmatseutilised saadused ja nende valmistamise meetod
DK314387D0 (da) Oralt ketotifenpraeparat
EE04154B1 (et) Omeprasooli valmistamise meetod
DE69432149T2 (de) Orale Zubereitungen
NO20004016L (no) Kosmetisk preparat inneholdende en forbindelse med aktivitetsstimulerende interlevkin-6
BR9705386A (pt) Fio dental
ATE237309T1 (de) Arzneizubereitungen
DE69733003D1 (de) Herstellung einer geschlitzten komponente
NO20001749D0 (no) Fremstilling av asymmetriske sykliske ureaforbindelser via et monoacylert diaminintermediat
FI974235A0 (fi) Ny bestaemningsmetod
NO20003284L (no) Farmasøytisk preparat for oral administrering

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee